Ohayon Maurice M
Stanford Sleep Epidemiology Research Center, Stanford University School of Medicine, 3430 W. Bayshore Road, Palo Alto, CA 94303, USA.
J Psychiatr Res. 2009 Jul;43(10):934-40. doi: 10.1016/j.jpsychires.2009.01.011. Epub 2009 Mar 3.
To assess the chronicity and severity of nocturnal awakenings with difficulty resuming sleep (DRS), its value as an indicator of an ongoing sleep and/or mental disorder and, finally, how it affects on daytime functioning.
A cross-sectional telephone study was performed in the non-institutionalized general population of France, the United Kingdom, Germany, Italy and Spain. This representative sample of 22,740 non-institutionalized individuals aged 15 or over was interviewed on their sleeping habits, health, sleep and mental disorders. These five European countries totaled 245.1 million inhabitants. The evaluation of nocturnal awakenings with DRS included duration, frequency (per night, per week and in the previous months) and assessment scale of daytime functioning. DRS was defined as a complaint of difficulty in resuming or inability to resume sleep occurring at least three nights per week and lasting for at least one month.
A total of 16.1% [95% CI: 15.6-16.6] of the sample had DRS. Prevalence was higher in women and increased with age. The average duration of DRS was 40 months. DRS individuals slept on average 30 min less than other subjects with insomnia symptoms and 60 min less than the rest of the sample. Painful physical conditions, anxiety and mood disorders were the most discriminative factors for individuals with DRS distinguishing them from other insomnia subjects and the rest of the sample. Daytime impairment was observed in 52.2% of DRS individuals compared to 32.8% in individuals with classical insomnia symptoms (p < 0.0001).
(1) DRS affect a large segment of the population; (2) it is a good indicator of an ongoing sleep or mental disorder; (3) it has a stronger impact on daytime functioning than classical insomnia symptoms (OR: 4.7).
评估伴有难以重新入睡(DRS)的夜间觉醒的慢性程度和严重程度、其作为持续睡眠和/或精神障碍指标的价值,以及最终它如何影响日间功能。
在法国、英国、德国、意大利和西班牙的非机构化普通人群中进行了一项横断面电话研究。对这个由22740名15岁及以上非机构化个体组成的代表性样本进行了关于他们睡眠习惯、健康状况、睡眠和精神障碍的访谈。这五个欧洲国家共有2.451亿居民。对伴有DRS的夜间觉醒的评估包括持续时间、频率(每晚、每周以及前几个月)和日间功能评估量表。DRS被定义为每周至少三个晚上出现难以重新入睡或无法重新入睡的主诉,且持续至少一个月。
样本中共有16.1%[95%置信区间:15.6 - 16.6]的人有DRS。患病率在女性中更高,且随年龄增长而增加。DRS的平均持续时间为40个月。有DRS的个体平均比其他有失眠症状的受试者少睡30分钟,比样本中的其他个体少睡60分钟。疼痛性身体状况、焦虑和情绪障碍是有DRS的个体与其他失眠受试者及样本中其他个体区分开来的最具鉴别性的因素。52.2%有DRS的个体出现了日间功能损害,而有经典失眠症状的个体中这一比例为32.8%(p < 0.0001)。
(1)DRS影响很大一部分人群;(2)它是持续睡眠或精神障碍的良好指标;(3)与经典失眠症状相比,它对日间功能的影响更大(比值比:4.7)。